Identification Generic Name (1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID DrugBank Accession Number DB07409 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID (DB07409) ×  Close Weight Average: 434.3161  Monoisotopic: 434.068426018  Chemical Formula C 20 H 20 O 7 P 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) Not Available Escherichia coli (strain K12) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as p-terphenyls. These are terphenyls with a structure containing the 1,4-diphenylbenzene skeleton. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Terphenyls Direct Parent P-terphenyls Alternative Parents Biphenyls and derivatives  /  Bisphosphonates  /  Organic phosphonic acids  /  Organopnictogen compounds  /  Organophosphorus compounds  /  Organooxygen compounds  /  Organic oxides  /  Hydrocarbon derivatives Substituents Aromatic homomonocyclic compound  /  Biphenyl  /  Bisphosphonate  /  Hydrocarbon derivative  /  Organic oxide  /  Organic oxygen compound  /  Organooxygen compound  /  Organophosphonic acid  /  Organophosphonic acid derivative  /  Organophosphorus compound Molecular Framework Aromatic homomonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key MPBUFKZCEBTBSK-UHFFFAOYSA-N InChI InChI=1S/C20H20O7P2/c21-20(28(22,23)24,29(25,26)27)14-15-5-4-8-19(13-15)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27) IUPAC Name (1-hydroxy-2-{4'-phenyl-[1,1'-biphenyl]-3-yl}-1-phosphonoethyl)phosphonic acid SMILES OC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O References General References Not Available External Links PubChem Compound 16122554 PubChem Substance 99443880 ChemSpider 17279473 BindingDB 25266 ChEMBL CHEMBL262616 PDBe Ligand B28 PDB Entries 2e9a Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.104 mg/mL ALOGPS logP 1.84 ALOGPS logP 2.75 Chemaxon logS -3.6 ALOGPS pKa (Strongest Acidic) 0.69 Chemaxon pKa (Strongest Basic) -5.2 Chemaxon Physiological Charge -3 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 5 Chemaxon Polar Surface Area 135.29 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 109.55 m 3 ·mol -1 Chemaxon Polarizability 41.53 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption - 0.5924 Blood Brain Barrier + 0.8783 Caco-2 permeable - 0.7143 P-glycoprotein substrate Non-substrate 0.6395 P-glycoprotein inhibitor I Non-inhibitor 0.8726 P-glycoprotein inhibitor II Non-inhibitor 0.9822 Renal organic cation transporter Non-inhibitor 0.9545 CYP450 2C9 substrate Non-substrate 0.7729 CYP450 2D6 substrate Non-substrate 0.8351 CYP450 3A4 substrate Non-substrate 0.6821 CYP450 1A2 substrate Non-inhibitor 0.8926 CYP450 2C9 inhibitor Non-inhibitor 0.8535 CYP450 2D6 inhibitor Non-inhibitor 0.9165 CYP450 2C19 inhibitor Non-inhibitor 0.8931 CYP450 3A4 inhibitor Non-inhibitor 0.9419 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9468 Ames test Non AMES toxic 0.8119 Carcinogenicity Non-carcinogens 0.6673 Biodegradation Not ready biodegradable 0.9258 Rat acute toxicity 2.0901 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9524 hERG inhibition (predictor II) Non-inhibitor 0.8467    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) Kind Protein Organism Escherichia coli (strain K12) Pharmacological action Unknown General Function Magnesium ion binding Specific Function Generates ditrans,octacis-undecaprenyl pyrophosphate (UPP) from isopentenyl pyrophosphate (IPP) and farnesyl diphosphate (FPP). UPP is the precursor of glycosyl carrier lipid in the biosynthesis of... Gene Name ispU Uniprot ID P60472 Uniprot Name Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) Molecular Weight 28443.92 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52 